Profil
Marko Bagaric is the founder of Berlin Heals Holding AG, where he currently holds the title of Chief Executive Officer & Director since 2014.
He is also currently the Chief Executive Officer of Berlin Cures GmbH and a Director at Berlin Cures Holding AG.
In the past, he worked as a Portfolio Manager at Swiss Invest Partners AG.
Aktive Positionen von Marko Bagaric
| Unternehmen | Position | Beginn |
|---|---|---|
Berlin Cures Holding AG
 Berlin Cures Holding AG BiotechnologyHealth Technology Part of Berlin Cures GmbH, Cures Holding AG is a Swiss joint stock company based in Zug, Switzerland. Cures Holding AG specializes in developing a neutralizer for pathogenic functional autoantibodies. The company is home to an unrivaled platform-technology established around BC 007. The company was founded in 2014 by Johannes Müller, and Oliver von Stein has been the CEO of the company since 2023. | Direktor/Vorstandsmitglied | - |
Berlin Cures GmbH
 Berlin Cures GmbH Pharmaceuticals: MajorHealth Technology Berlin Cures GmbH engages in the development and production of a drug for the treatment of chronic heart failure. The company was founded on September 9, 2014 and is headquartered in Berlin, Germany. | Vorstandsvorsitzender | - |
Berlin Heals Holding AG
 Berlin Heals Holding AG Medical SpecialtiesHealth Technology Part of Berlin Heals GmbH, the company is a medical device company based in Zug, Switzerland. The Swiss company develops implantable medical devices for the cure of heart failure. The company was founded in 2014 by Johannes Müller, Marko Bagaric, Peter Goettel. Marko Bagaric has been the CEO since 2014. | Gründer | 01.01.2014 |
Ehemalige bekannte Positionen von Marko Bagaric
| Unternehmen | Position | Ende |
|---|---|---|
| Swiss Invest Partners AG | Portfolio Manager-Aktien | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
| Swiss Invest Partners AG | Finance |
Berlin Cures GmbH
Berlin Cures GmbH Pharmaceuticals: MajorHealth Technology Berlin Cures GmbH engages in the development and production of a drug for the treatment of chronic heart failure. The company was founded on September 9, 2014 and is headquartered in Berlin, Germany. | Health Technology |
Berlin Cures Holding AG
Berlin Cures Holding AG BiotechnologyHealth Technology Part of Berlin Cures GmbH, Cures Holding AG is a Swiss joint stock company based in Zug, Switzerland. Cures Holding AG specializes in developing a neutralizer for pathogenic functional autoantibodies. The company is home to an unrivaled platform-technology established around BC 007. The company was founded in 2014 by Johannes Müller, and Oliver von Stein has been the CEO of the company since 2023. | Health Technology |
Berlin Heals Holding AG
Berlin Heals Holding AG Medical SpecialtiesHealth Technology Part of Berlin Heals GmbH, the company is a medical device company based in Zug, Switzerland. The Swiss company develops implantable medical devices for the cure of heart failure. The company was founded in 2014 by Johannes Müller, Marko Bagaric, Peter Goettel. Marko Bagaric has been the CEO since 2014. | Health Technology |
